On January 10, Pluristem Therapeutics Inc. (PSTI) announced its collaboration with Tnuva for establishing a cultured food platform. Consequently, the stock was trading at $1.85
Pluristem Therapeutics Inc. (Nasdaq: PSTI) share nose-dived in the premarket session after the announcement by a leading regenerative medicine firm building a marketplace for new
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.